James Creeden

Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors

Coren A. Milbury, James Creeden, Wai‐Ki Yip et al. · PLoS ONE · 2022 · 357 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer

Ryon P. Graf, Virginia Fisher, Janick Weberpals et al. · JAMA Network Open · 2022 · 88 citations · Full text

Medicine, Biostatistics, Oncology +17

Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective

Nandini Hadker, Suchita Garg, Cory Costanzo et al. · Journal of Medical Economics · 2010 · 64 citations

Medicine, Maternal Health, Obstetrics +15

Cost-Effectiveness of Erlotinib versus Docetaxel for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in the United Kingdom

G Lewis, Michael Peake, R Aultman et al. · Journal of International Medical Research · 2010 · 43 citations

Pharmacy, Oncology, Pharmacoeconomics +17

Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases

Richard S.P. Huang, Lukas Harries, Brennan Decker et al. · The Oncologist · 2022 · 43 citations · Full text

Medicine, Molecular Genetics, Oncology +17